Product Images Teriflunomide

This appears to be data related to the effectiveness of the medications Placebo, 7mg Teriflunomide, and 14mg Teriflunomide in slowing down disability progression for 12 weeks. The data appears to be presented in a graph and a table, showing the number of people using each medication and the sustained disability progression for each week.*

This is a medication description for Teriflunomide tablets containing 7 mg of the medicine. It is taken orally once every day, with or without food. The medication should be stored at temperatures of 20° to 25°C (68° to 77°F) and kept away from children. This medication is manufactured by AET Laboratories Pyt Ltd for Sandoz Inc, in Princeton, NJ 08540.*

Teriflunomide is a medication used orally to treat relapsing forms of multiple sclerosis (MS). Each tablet with a code number of DRUGS/AP/5/2006 contains 14 mg of teriflunomide. It is recommended to take one tablet daily, with or without food, as per the package insert. A Medication Guide is enclosed and should be dispensed by pharmacists. Teriflunomide tablets must be kept out of reach of children and stored at USP controlled room temperature. The tablets are manufactured by AET Laboratories Pyt Ltd for Sandoz Inc, in Princeton, NJ, USA. The latest revision date is 02/2022.*